Rapid Progressive Liver Atrophy During Immune Checkpoint Inhibitor Hepatitis: Imaging Perspectives Beyond Aminotransferase Elevation
Chukwuka Elendu, Adetokunbo A. Adesina, Olisa S. Okabekwa, Ebube C. Mbah, Favour K. Mbakwe · 2026
Read Rapid Progressive Liver Atrophy During Immune Checkpoint Inhibitor Hepatitis: Imaging Perspectives Beyond Aminotransferase Elevation by Chukwuka Elendu, Adetokunbo A. Adesina, Olisa S. Okabekwa, Ebube C. Mbah, Favour K. Mbakwe (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13304220.txt.
Description
Chukwuka Elendu and co-authors write a 2026 letter on liver shrinkage during immune drug hepatitis, responding to a fatal case report. Checkpoint drugs help liver cancer patients, but immune attack on the liver can turn deadly even when blood enzyme rises stay small.
In scarred livers, few working cells remain to leak enzymes, so standard blood tests can badly understate true damage. Fast liver shrinkage on scans may warn of failure sooner than enzyme grades suggest. The letter urges teams to weigh scans, symptoms, and specialist input together rather than trusting enzyme numbers alone in patients with cirrhosis.
Catalog record
| CREATOR | Chukwuka Elendu, Adetokunbo A. Adesina, Olisa S. Okabekwa, Ebube C. Mbah, Favour K. Mbakwe |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 8358 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |